phase 0_trial_completion
saveNational Key Research and Development Program — undisclosed sodium glucose cotransporter 2 inhibitor (Phase 0 Trial Completion)
community read0 votes
Therapy area: Metabolic Disorders. Indication: Type 2 Diabetes
Data sources
globaldata
Found something off?
comments(0)
5-min edit window · permanent after that